The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of KITE-363 anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients (pts) with relapsed/refractory (R/R) B-cell lymphoma (BCL).
 
Saurabh Dahiya
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol Myers Squibb; Kite/Gilead
 
Matthew Ulrickson
Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kura Oncology; Stemline Therapeutics
Research Funding - Immunogen; Kite, a Gilead company
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Max Topp
Consulting or Advisory Role - Abbvie; AstraZeneca; Autolus; Bristol-Myers Squibb; Incyte; Janssen; Kite, a Gilead Company
Research Funding - AstraZeneca; Regeneron; Roche
Travel, Accommodations, Expenses - BeiGene; Kite, a Gilead Company
 
Marie Kersten
Consulting or Advisory Role - Adicet Bio; Bristol-Myers Squibb/Celgene; Kite, a Gilead Company; Miltenyi Biotec; Novartis; Roche
Research Funding - Kite, a Gilead Company (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead Company; Miltenyi Biotec; Novartis; Roche
 
Jean Yared
Stock and Other Ownership Interests - Incyte
Research Funding - Abbvie; AlloVir; Gilead Sciences; Jazz Pharmaceuticals; Kite, a Gilead Company; Priothera; REGiMMUNE; Shire
 
Patrick Reagan
Consulting or Advisory Role - Caribou Biosciences; Kite, a Gilead company
Research Funding - Genentech/Roche; Seagen
 
Ran Reshef
Consulting or Advisory Role - Allogene Therapeutics; Autolus Therapeutics; Gilead Sciences; Incyte; Orca Bio; Quell Biotherapeutics; Sana Biotechnology; TScan Therapeutics
Research Funding - Abbvie (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Cabaletta Bio (Inst); CareDX (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); immatics (Inst); Incyte (Inst); Janssen (Inst); Precision Biosciences (Inst); Sanofi (Inst); Synthekine (Inst); Takeda (Inst); TCR2 Therapeutics (Inst); TScan Therapeutics (Inst)
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Robin Sanderson
Honoraria - AstraZeneca; Kite, a Gilead Company
Speakers' Bureau - Abbvie; AstraZeneca; Kite, a Gilead Company
Travel, Accommodations, Expenses - AstraZeneca; Kite, a Gilead Company
 
Timothy Voorhees
Consulting or Advisory Role - AbbVie/Genmab; ADC Therapeutics; Novartis; Recordati
Research Funding - AbbVie/Genmab; Incyte/MorphoSys; Kite, a Gilead Company; Recordati; Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Recordati
 
Sairah Ahmed
Honoraria - ADC Therapeutics; Genmab; Kite/Gilead
Consulting or Advisory Role - Kite/Gilead; Myeloid Therapeutics
Research Funding - Caribou Biosciences (Inst); Chimagen Biosciences (Inst); Genmab/Seattle Genetics (Inst); Janssen Oncology (Inst); Merck (Inst); Nektar (Inst)
 
A. Jung
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Amgen; Gilead Sciences; Kura Oncology; Turning Point Therapeutics
 
Enrique Granados
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Jinghui Dong
Employment - Kite, a Gilead Company
 
Joshua Winters
Employment - Kite, a Gilead Company
 
Justyna Kanska
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Myrna Nahas
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Loretta Nastoupil
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Genmab; Gilead Sciences; Incyte; Ipsen; Janssen Oncology; Novartis
Consulting or Advisory Role - Interius Biotherapeutics; SIRPant Immunotherapeutics
Research Funding - Allogene Therapeutics; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Daiichi Sankyo/UCB Japan; Genentech/Roche; Genmab; Gilead Sciences; Ipsen; Janssen Biotech; Novartis